In patients receiving tirzepatide, the downstream activation of GLP-1 and GIP receptor-mediated molecular pathways, especially in those with chronic pancreatitis, could increase the risk of developing pancreatic cancer [41]
Anil Makam, M.D., an internal medicine physician at the University of California, San Francisco, notes that GLP-1s may be a future therapeutic option for people with substance use disorders
The SELECT trial benefit accumulates over time
Its also a great base for smoothies if youre looking for something cool during hot weather
Your GP or endocrinologist should ideally liaise with your IBD specialist before prescribing Ozempic, ensuring coordinated care
For tesamorelin, the VAT reduction achieved during treatment is partially reversed within 612 months of discontinuation a finding clearly documented in the clinical trial literature